非复制型表达载体：在疫苗开发和基因治疗中的应用
Non-replicating expression vectors: applications in vaccine development and gene therapy.
作者信息
Limbach K J, Paoletti E
机构信息
Virogenetics Corporation, Rensselaer Technology Park, Troy, New York 12180, USA.
出版信息
Epidemiol Infect. 1996 Jun;116(3):241-56. doi: 10.1017/s0950268800052547.
Abstract
This review presents experimental, preclinical and clinical data illustrating the multiple uses of recombinant non-replicating virus vectors in the fields of immunoprophylaxis and gene therapy.
摘要
本综述展示了实验、临床前和临床数据，阐明了重组非复制病毒载体在免疫预防和基因治疗领域的多种用途。
相似文献
1
Non-replicating expression vectors: applications in vaccine development and gene therapy.非复制型表达载体：在疫苗开发和基因治疗中的应用
Epidemiol Infect. 1996 Jun;116(3):241-56. doi: 10.1017/s0950268800052547.
2
Gene therapy and viral vaccination: the interface.基因治疗与病毒疫苗接种：交叉领域
Br Med Bull. 1995 Jan;51(1):205-16. doi: 10.1093/oxfordjournals.bmb.a072947.
3
Adenovirus-based expression vectors and recombinant vaccines.基于腺病毒的表达载体和重组疫苗。
Biotechnology. 1992;20:363-90. doi: 10.1016/b978-0-7506-9265-6.50022-1.
4
An overview of vaccine vectors.疫苗载体概述。
Dev Biol Stand. 1995;84:23-32.
5
Highly attenuated poxvirus vectors.高度减毒痘病毒载体
AIDS Res Hum Retroviruses. 1992 Aug;8(8):1445-7. doi: 10.1089/aid.1992.8.1445.
6
Rapid-response manufacturing of adenovirus-vectored vaccines.腺病毒载体疫苗的快速响应制造。
Nat Biotechnol. 2023 Mar;41(3):314-316. doi: 10.1038/s41587-023-01682-2.
7
Gene therapy and gene transfer approaches to prevent or treat chronic virus infections.用于预防或治疗慢性病毒感染的基因治疗和基因转移方法。
Adv Exp Med Biol. 2015;848:v-vii.
8
Recombinant adenoviruses as vaccines.重组腺病毒作为疫苗。
Biologicals. 1995 Jun;23(2):145-57. doi: 10.1006/biol.1995.0025.
9
Experimental treatments for HIV-infected patients.针对HIV感染患者的实验性治疗。
Am Fam Physician. 1989 Jun;39(6):330.
10
Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC.高度减毒痘病毒载体：NYVAC、ALVAC和TROVAC。
Dev Biol Stand. 1995;84:159-63.
引用本文的文献
1
COVID-19 Vaccines: An Overview of Different Platforms.新冠疫苗：不同平台概述
Bioengineering (Basel). 2022 Feb 12;9(2):72. doi: 10.3390/bioengineering9020072.
2
Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition.ALVAC-SIV 疫苗接种可使单核细胞、NK 细胞和 CD4+ Th1 细胞参与其中，从而降低 SIVmac251 阴道感染的风险。
PLoS Pathog. 2020 Mar 12;16(3):e1008377. doi: 10.1371/journal.ppat.1008377. eCollection 2020 Mar.
3
Synthetic DNA vaccine strategies against persistent viral infections.针对持续性病毒感染的合成 DNA 疫苗策略。
Expert Rev Vaccines. 2013 May;12(5):537-54. doi: 10.1586/erv.13.33.
4
Immunoprophylaxis against important virus disease of horses, farm animals and birds.针对马、家畜和禽类重要病毒性疾病的免疫预防。
Vaccine. 2009 Mar 13;27(12):1797-1810. doi: 10.1016/j.vaccine.2008.12.063.
5
Characterization of avipoxviruses from wild birds in Norway.挪威野生鸟类禽痘病毒的特征分析。
Can J Vet Res. 2004 Apr;68(2):140-5.
6
Identification and characterization of three immunodominant structural proteins of fowlpox virus.禽痘病毒三种免疫显性结构蛋白的鉴定与特性分析
J Virol. 2002 Oct;76(19):9844-55. doi: 10.1128/jvi.76.19.9844-9855.2002.
7
The 131-amino-acid repeat region of the essential 39-kilodalton core protein of fowlpox virus FP9, equivalent to vaccinia virus A4L protein, is nonessential and highly immunogenic.禽痘病毒FP9必需的39千道尔顿核心蛋白的131个氨基酸重复区域，等同于痘苗病毒A4L蛋白，是非必需的且具有高度免疫原性。
J Virol. 1998 Jan;72(1):170-9. doi: 10.1128/JVI.72.1.170-179.1998.
8
The Jenner bicentenary; still uses for smallpox vaccine.詹纳诞辰二百周年；天花疫苗仍在使用。
Epidemiol Infect. 1996 Jun;116(3):231-4. doi: 10.1017/s0950268800052523.
本文引用的文献
1
Isogenic adenoviruses type 5 expressing or not expressing the E1A gene: efficiency as virus vectors in the vaccination of permissive and non-permissive species.表达或不表达E1A基因的5型同基因腺病毒：作为病毒载体在允许和非允许物种疫苗接种中的效率
J Gen Virol. 1995 Jul;76 ( Pt 7):1583-9. doi: 10.1099/0022-1317-76-7-1583.
2
Mouse hepatitis virus spike and nucleocapsid proteins expressed by adenovirus vectors protect mice against a lethal infection.腺病毒载体表达的小鼠肝炎病毒刺突蛋白和核衣壳蛋白可保护小鼠免受致死性感染。
J Gen Virol. 1993 Oct;74 ( Pt 10):2061-9. doi: 10.1099/0022-1317-74-10-2061.
3
Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL.用金丝雀痘病毒重组体ALVAC-FL对猫进行疫苗接种以预防猫白血病病毒。
J Virol. 1993 Apr;67(4):2370-5. doi: 10.1128/JVI.67.4.2370-2375.1993.
4
Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin.
J Gen Virol. 1993 Mar;74 ( Pt 3):501-7. doi: 10.1099/0022-1317-74-3-501.
5
Human gene therapy.人类基因治疗。
Annu Rev Biochem. 1993;62:191-217. doi: 10.1146/annurev.bi.62.070193.001203.
6
Immunogenicity of recombinant human adenovirus-human immunodeficiency virus vaccines in chimpanzees.重组人腺病毒-人类免疫缺陷病毒疫苗在黑猩猩中的免疫原性。
AIDS Res Hum Retroviruses. 1993 May;9(5):395-404. doi: 10.1089/aid.1993.9.395.
7
In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs.血友病B的体内基因治疗：在IX因子缺陷犬中实现持续部分纠正
Science. 1993 Oct 1;262(5130):117-9. doi: 10.1126/science.8211118.
8
Adenoviral interleukin-2 gene transfer into P815 tumor cells abrogates tumorigenicity and induces antitumoral immunity in mice.
Hum Gene Ther. 1993 Dec;4(6):703-11. doi: 10.1089/hum.1993.4.6-703.
9
Adenovirus vector-mediated in vivo gene transfer into adult murine retina.腺病毒载体介导的体内基因转移至成年小鼠视网膜。
Invest Ophthalmol Vis Sci. 1994 Apr;35(5):2535-42.
10
In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs.体内肝脏基因治疗：血友病B犬中因子IX缺乏症的完全纠正，尽管是短暂的。
Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2353-7. doi: 10.1073/pnas.91.6.2353.
Zotero 插件